Globus Medical Inc (N:GMED)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 2560 General Armistead Ave
AUDUBON PA 19403-5214
Tel: 1-610-9301800
Website: https://www.globusmedical.com
IR: See website
<
Key People
David C. Paul
Executive Chairman of the Board
Daniel T. Scavilla
President, Chief Executive Officer, Director
Keith W. Pfeil
Chief Financial Officer, Chief Operating Officer
Kelly Grace Huller
Senior Vice President, General Counsel, Corporate Secretary
   
Business Overview
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Financial Overview
For the fiscal year ended 31 December 2023, Globus Medical Inc revenues increased 53% to $1.57B. Net income decreased 35% to $122.9M. Revenues reflect Musculoskeletal Solutions products segment increase of 56% to $1.45B, Enabling Technologies products segment increase of 25% to $120.2M, United States segment increase of 47% to $1.28B, International segment increase of 91% to $288.7M. Net income was offset by Selling.
Employees: 5,000 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $7,162M as of Dec 31, 2023
Annual revenue (TTM): $1,568M as of Dec 31, 2023
EBITDA (TTM): $347.49M as of Dec 31, 2023
Net annual income (TTM): $122.87M as of Dec 31, 2023
Free cash flow (TTM): $165.23M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 136,335,662 as of Feb 16, 2024
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.